These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11363336)

  • 1. Saquinavir: newest weapon in the antiviral arsenal.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):25-31. PubMed ID: 11363336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lottery opens 2,000 slots for protease trial.
    AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saquinavir thwarts resistance.
    AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European hurdles for saquinavir.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grapefruit juice and saquinavir.
    James JS
    AIDS Treat News; 1995 Nov; (no 235):5-6. PubMed ID: 11363047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roche submits NDA for Invirase.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinder, gentler ddC... for $7,200 a year.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitor: Roche lottery deadline July 21.
    AIDS Treat News; 1995 Jul; (no 226):4-5. PubMed ID: 11362614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saquinavir (Invirase).
    Treat Rev; 1996 Apr; (no 21):5. PubMed ID: 11363396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saquinavir gets accelerated approval.
    McGuire S
    Posit Aware; 1996; 7(1):8. PubMed ID: 11363135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hoffmann-LaRoche announces international compassionate treatment program for saquinavir.
    J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):32-4. PubMed ID: 11362607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roche investigators say Invirase does not cause cross-resistance to other protease inhibitors.
    Baker R
    BETA; 1995 Sep; ():5. PubMed ID: 11362895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saquinavir (Roche protease inhibitor) at higher doses.
    AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No tease this time--pros and cons of a long-awaited anti-HIV drug.
    Chang HE
    Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves 3TC and saquinavir. Food and Drug Administration.
    Baker R
    BETA; 1995 Dec; ():5, 9. PubMed ID: 11363011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
    AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why the old saquinavir (Invirase) may be bad for your health.
    Vazquez E
    Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invirase program expands.
    AIDS Patient Care; 1995 Dec; 9(6):305. PubMed ID: 11361444
    [No Abstract]   [Full Text] [Related]  

  • 20. Protease inhibitor expanded access.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):3. PubMed ID: 11362689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.